Alexandros Patsilinakos

According to our database, Alexandros Patsilinakos authored at least 5 papers between 2015 and 2024.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of four.

2024

Pliability in the m⁶A-Binding Region Extends Druggability of YTH Domains.

Giulia Cazzanelli, Andrea Dalle Vedove, Giovanni Spagnolli, Luca Terruzzi, Enrica Colasurdo, Alberto Boldrini, Alexandros Patsilinakos, Mattia Sturlese, Alessandro Grottesi, Emiliano Biasini, Alessandro Provenzani, Alessandro Quattrone, Graziano Lolli

J. Chem. Inf. Model., March, 2024

2020

Machine learning applications to essential oils and natural extracts.

Alexandros Patsilinakos

PhD thesis, 2020

2018

Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches.

Manuela Sabatino, Dante Rotili, Alexandros Patsilinakos, Mariantonietta Forgione, Daniela Tomaselli, Fréderic Alby, Paola B. Arimondo, Antonello Mai, Rino Ragno

J. Comput. Aided Mol. Des., 2018

2017

Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2<i>H</i>-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.

Milan Mladenovic, Alexandros Patsilinakos, Adele Pirolli, Manuela Sabatino, Rino Ragno

J. Chem. Inf. Model., 2017

2015

Vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors: development and validation of predictive 3-D QSAR models through extensive ligand- and structure-based approaches.

Rino Ragno, Flavio Ballante, Adele Pirolli, Richard B. Wickersham III, Alexandros Patsilinakos, Stéphanie Hesse, Enrico Perspicace, Gilbert Kirsch

J. Comput. Aided Mol. Des., 2015